About Juno | Our Story | Juno Therapeutics

Bringing Innovation Out of the Lab

More than 25 years ago, researchers at Fred Hutchinson Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children’s Research Institute and elsewhere were working in the lab on the development of T cells against foreign antigens. This early work was ground breaking, ultimately defining the principles for producing investigational adoptive T cell therapy, and eventually, CAR T cells. By the mid-2000s, this research moved into patient clinical trials.


50 employees by year end


Juno launches first pivotal trial

JuMP manufacturing facility opens in Bothell, WA

New headquarters development initiated

300 employees by year end


New Immuno-oncology Clinical Trials Unit at Fred Hutchinson Cancer Research Center opens with support from Juno

Juno employees raise over $100,000 in fundraising for The Leukemia & Lymphoma Society and Fred Hutch

500+ employees by year end


Juno becomes a Celgene company